We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Dietary Manipulation Modifies Protein Linked to Nephrotic Syndrome

By LabMedica International staff writers
Posted on 27 Dec 2010
Researchers have identified a secreted glycoprotein that plays a key role in the development of nephrotic syndrome (NS), a disorder that results in severe imbalance in protein levels between an individual's blood serum and urine.

Nephrotic syndrome is a nonspecific disorder in which the kidneys are damaged, causing them to leak large amounts of protein from the blood into the urine. More...
Kidneys affected by nephrotic syndrome have small pores in the podocytes, large enough to permit proteinuria (and subsequently hypoalbuminemia, since some of the protein albumin has gone from the blood to the urine) but not large enough to allow cells through (hence no hematuria).

Common causes of NS include diabetic nephropathy, minimal change disease (the most common cause of NS in children under 10 years of age), focal and segmental glomerulosclerosis, and membranous nephropathy. It also can be caused by infections, certain drugs, cancer, genetic disorders, immune disorders, or diseases that affect multiple body systems including lupus, multiple myeloma, and amyloidosis. Treatment for NS is usually based on glucocorticoids, for example prednisone, and other immunosuppressive drugs that can have significant toxicity, especially after prolonged use or repeated cycles of treatment.

Investigators at the University of Alabama (Birmingham, USA) worked with a transgenic rat model that mimicked human minimal change disease. They reported in the December 12, 2010 online edition of the journal Nature Medicine that these mice demonstrated highly elevated expression of the secreted glycoprotein angiopoietin-like-4 (Angptl4). Overexpression of Angptl4 in rat kidney tissue induced nephrotic disease-like, selective proteinuria (over 500-fold increase in albuminuria), loss of glomerular basement membrane (GBM) charge and foot process effacement, while transgenic expression specifically in adipose tissue resulted in increased circulating Angptl4, but no proteinuria.

Close examination at the molecular level revealed that the Angptl4 secreted from podocytes from rats with nephrotic syndrome lacked the normal number of attached sialic acid residues. In an attempt to increase the amount of sialic acid in Angpt14, the investigators fed the rats the sialic acid precursor N-acetyl-D-mannosamine (ManNAc). They found that this treatment increased the sialylation of Angptl4 and decreased albuminuria by more than 40%.

"This is a major breakthrough in understanding the development and treatment of kidney disease associated with proteinuria, the leakage of protein in the urine," said senior author Dr. Sumant Singh Chugh, MD, associate professor of medicine at the University of Alabama. "These findings, at present, most directly relate to minimal change disease, a form of nephrotic syndrome commonly seen in children, but are also likely to be relevant to common causes of proteinuria and nephrotic syndrome in adults, including those with diabetes."

"The major known toxicity of sialic acid therapy observed by other investigators in a mouse model of the human muscle disease, hereditary inclusion body myopathy, was the development of ovarian cysts at very high doses," said Dr. Chugh. "These doses are approximately 20-fold higher than those used to reduce proteinuria in rats in the current study; knowing that, we believe sialic acid repletion has potential in the future treatment of minimal change disease and some other forms of nephrotic syndrome."

Related Links:
University of Alabama


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Modular Hemostasis Automation Solution
CN Track
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.